Emcure Pharmaceuticals Limited (BOM: 544210)
India
· Delayed Price · Currency is INR 1,388.00
+26.65 (1.96%)
At close: Jan 20, 2025
Emcure Pharmaceuticals Revenue
Emcure Pharmaceuticals had revenue of 20.02B INR in the quarter ending September 30, 2024, with 20.38% growth. This brings the company's revenue in the last twelve months to 72.56B, up 13.13% year-over-year. In the fiscal year ending March 31, 2024, Emcure Pharmaceuticals had annual revenue of 66.58B with 11.23% growth.
Revenue (ttm)
72.56B
Revenue Growth
+13.13%
P/S Ratio
n/a
Revenue / Employee
6.69M
Employees
10,852
Market Cap
257.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 66.58B | 6.72B | 11.23% |
| Mar 31, 2023 | 59.86B | 1.30B | 2.23% |
| Mar 31, 2022 | 58.55B | 8.22B | 16.33% |
| Mar 31, 2021 | 50.33B | -150.80M | -0.30% |
| Mar 31, 2020 | 50.49B | 3.31B | 7.02% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2012 | Pro | Pro | Pro |
| Mar 31, 2011 | Pro | Pro | Pro |
| Mar 31, 2010 | Pro | Pro | Pro |
| Mar 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,761.06B |
| Bharti Airtel | 1,554.78B |
| ICICI Bank | 1,638.51B |
| Infosys | 1,635.60B |
| State Bank of India | 3,360.28B |
| ITC Limited | 751.35B |